All News #Library
Others
ZZ Biotech’s Stroke Drug Moves Closer to Pivotal PIII Trial
24 May 2022 //
BUSINESSWIRE
ZZ Biotech Begins Dosing in Phase 2 Trial of 3K3A-APC for ALS
02 Dec 2021 //
BUSINESSWIRE

Market Place
Sourcing Support